Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Shares of Eden Research plc (LON:EDEN) traded down 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The stock’s 50 day simple moving average is GBX 3.87 and its two-hundred day simple moving average is GBX 3.95.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.